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Abstract
Cross-presentation, which is crucial for the generation of immunity against virus-infected and
tumor cells, requires exogenous antigens to be internalized into antigen-presenting cells (APCs)
followed by translocation to the cytosol by unknown mechanisms. One important entry route for such
antigens is macropinocytosis. We here describe that cholesterol is essential for cross-presentation of
antigens loaded via macropinocytosis into APCs. Modification of antigens by palmitoylation to target
antigens to cholesterol-enriched plasma membrane domains resulted in a dramatically increased
T cell activation. These results define cholesterol as an essential factor for cross-presentation
and suggest that specific modification of antigens to increase their affinity for cholesterol may be
utilized to enhance immunity.
Introduction
Generation of an immune response occurs through the activ-
ity of the MHC class I and MHC class II molecules, whose
function is to present foreign peptides to CD8 and CD4
positive lymphocytes, respectively. MHC class II molecules
form a complex with an invariant chain in the endoplasmic
reticulum (ER) and are targeted to post-Golgi endosomal/
lysosomal organelles, the so-called MHC class II compart-
ments (1–3). Within these organelles, they assemble with
peptides derived from exogenous antigens that are internal-
ized via endocytosis and degraded in endosomal/lysosomal
organelles (4–7). These intracellularly formed MHC class
II–peptide complexes are then transported to the cell surface
for presentation to CD4+ (helper) T lymphocytes (8).
MHC class I molecules, in contrast, are synthesized in
the ER, assemble with beta 2-microglobulin and remain in the
ER until they become loaded with antigenic peptides (9).
Antigenic peptides loaded onto MHC class I molecules are
derived from antigens as well as infectious agents that reside
in the cytosol, such as viral proteins as well as tumor-derived
antigens (10, 11). These cytosolic antigens are degraded by
proteasome, a cytosolic multi-protease complex, into peptides
(12, 13), which are subsequently translocated into the ER in
an ATP-dependent manner by the transporter associated with
antigen processing (TAP) (14, 15). Assembly of antigenic
peptides with the MHC class I/beta 2-microglubulin complex
in the ER triggers their transport to the cell surface where they
can activate CD8+ (killer) T lymphocytes (16). This dichotomy
between the MHC class I and class II pathways ensures the
efficient and selective killing of virally infected or tumor cells,
while generating a help response in case of bacterial
infections (4, 17). In addition, restricting MHC class I pre-
sentation to endogenous antigens prevents healthy cells from
becoming targets for killing by CD8+ T lymphocytes (18).
An important step in the generation of an immune response
is the activation of naive T cells, which occurs through their
stimulation by dendritic cells (19–21). Dendritic cells sample
peripheral tissue for the presence of antigens and migrate
to lymphoid organs where antigenic peptides captured at
the periphery can be presented to naive T lymphocytes (20).
For the generation of CD4+ T lymphocytes, antigens are
captured within the endocytic pathway, and during migration
to the secondary lymphoid organs the dendritic cells mature
and increase the expression of MHC class II–peptide com-
plexes at the cell surface in order to efficiently induce T cell
activation (22–24). How CD8+ Tcells can be activated against
antigens present in the periphery has been less well defined.
For generation of CD8+ T lymphocytes, antigens captured in
the periphery by professional antigen-presenting cells (APCs)
have to acquire access to the MHC class I pathway. It is now
becoming clear that a pathway does exist both in dendritic
Correspondence to: J. Pieters; E-mail: jean.pieters@unibas.ch Received 15 May 2005, accepted 17 February 2006
Transmitting editor: H. Ploegh Advance Access publication 11 April 2006
International Immunology, Vol. 18, No. 5, pp. 755–765
doi:10.1093/intimm/dxl013
ª The Japanese Society for Immunology. 2006. All rights reserved.
For permissions, please e-mail: journals.permissions@oxfordjournals.org
cells and macrophages to deliver exogenously captured anti-
gens to the MHC class I-processing compartments referred
to as cross-presentation (21, 25–27). Cross-presentation
is crucial for the establishment of immunity against virus-
infected and tumor-transformed cells as well as for the
induction of tolerance (21, 28). The precise mechanisms in-
volved in transfer of exogenous antigens to the MHC class
I-processing and -presentation machinery are still unclear
(6, 18, 29, 30, 70).
One internalization route used by macrophages and den-
dritic cells in particular to sample exogenous antigens to be
cross-presented is macropinocytosis (17, 31–34). Macro-
pinocytosis refers to the uptake of non-particulate material
through the formation of 0.5- to 2-lm diameter vesicles in an
actin-dependent process (35). Macropinosome formation
starts at the cell periphery by extension of a large planar
membrane ruffle (lamellipodium) that folds back to form
the macropinosome (36–39). In macrophages and dendritic
cells, formation of macropinosomes is a constitutive activity,
which can be further enhanced by treatment with growth
factors and activators of protein kinase C such as phorbol
esters. Also in other cell types, macropinocytosis can be
induced, although the significance of such macropinocytic
events for internalization processes in these cells is unclear
(35, 40, 41). Both induced and constitutive macropinosome
formations are dependent on the activity of phosphatidylino-
sitol (PI)-3-kinase (38, 42) and the activity of Rho family
member Rac 1 (43, 44). Whereas activation of GTPase Rac 1
and its subsequent signaling to downstream effectors such
as WAVE 2, an activator of the Arp2/3 complex (45, 46) or
p21-activated kinases (47) is required for the rearrangement
of the actin cytoskeleton, activated PI-3-kinase seems to be
necessary for the completion of macropinosome formation
(38). Macropinosomes remain separate from conventional
endosomes (48), although fluid-phase markers internalized
via macropinocytosis may eventually reach lysosomes (49).
Antigens internalized into APC via macropinocytosis gain
access to the MHC class I-processing pathway (28, 32, 50)
but the mechanisms involved in the transfer of macropinocy-
tosed antigens to the cytosol remain unknown. As a first
step toward defining the molecular events involved in the
transfer of exogenous antigens to the MHC class I-processing
and -presentation pathways, we analyzed the delivery of a
model antigen, ovalbumin, to the class I-presentation pathway.
We found that the steroid plasma membrane component
cholesterol is essential for entry of ovalbumin into the class I
pathway. Furthermore, chemical modification of ovalbumin
to increase its affinity for cholesterol dramatically enhanced
the capacity of the APCs to stimulate T lymphocytes.
Methods
Cells, antibodies and reagents
J774A.1 cells (American Type Tissue Collection) were main-
tained in DMEM (GIBCO) supplemented with 2 mM glutamine
(GIBCO) and 10% FCS (GIBCO). Primary cells were obtained
from isolated bone marrow of C57/BL6 mice. For generation
of macrophages, the bone marrow cells were grown for 7 days
in DMEM containing 10% FCS, 5% horse serum (GIBCO),
2 mM glutamine, 1 mM sodium pyruvate (GIBCO), 0.5 mM
b-mercaptoethonal (GIBCO) and 30% L929-conditioned
media. To obtain immature dendritic cells from bone marrow-
derived precursor cells, DMEM was supplemented with 1%
glutamine, 10% FCS and 25 ng ml1 granulocyte macrophage
colony-stimulating factor (Genzyme, Diagnostic). After 3 days
of culture, 1.5 ng ml1 interleukin-4 (R &D Systems) was
added. FITC–Dextran (2 000 000 MW) was purchased from
Molecular Probes. Methyl-b-cyclodextrin, ovalbumin, meva-
lonic acid, filipin complex III, horse radish peroxidase (HRP)
and palmitic-acid-N-hydroxysuccinimid-ester (NHS–palmitic
acid) were obtained from Sigma and phorbol myristate acetate
(PMA) and lovastatin from Calbiochem.
Antibodies against lysosomal-associated membrane
glycoprotein-1 (LAMP-1) (ID4B) were obtained from the
Developmental Studies Hybridoma Bank developed under
the auspices of the NICHD and maintained by The University
of Iowa, Department of Biological Sciences, Iowa City, IA
52242, USA. As a secondary reagent, anti-rat IgG (H + L)-
568 (Molecular Probes) was used. Clathrin was stained
using mouse anti-clathrin (Transduction Laboratories) and
anti-mouse IgG1-TXR (Southern Biotechnology Association
Inc.) antibodies.
Preparation of the cholesterol–methyl-b-cyclodextrin
inclusion complex
The synthesis of the cholesterol–methyl-b-cyclodextrin com-
plex was performed as described before (51). In brief, 30 mg
cholesterol was dissolved in 2-propanol and added in small
aliquots to a stirred solution of 1 mg methyl-b-cyclodextrin
(5% w/v) on a water bath (80C). Stirring was continued until
everything was dissolved. After the removal of solvents by
freeze drying, the cholesterol–methyl-b-cyclodextrin com-
plexes were stored at room temperature (RT).
Cholesterol depletion and replenishment
Cholesterol depletion was performed as described in (56). In
brief, cells were grown in the presence of 4 lM lovastatin (10
mM stock solution in 10% ethanol) and 250 lM mevalonate
(J774A.1 for 60 h, bone marrow-derived macrophages and
dendritic cells for 108 h) after which the residual plasma mem-
brane cholesterol was extracted with methyl-b-cyclodextrin
(J774A.1: 10 mM methyl-b-cyclodextrin for 45 min; bone
marrow-derived macrophages: 20 mM methyl-b-cyclodextrin
for 75 min; bone marrow-derived dendritic cells: 15 mM methyl-
b-cyclodextrin for 45 min). All subsequent experiments were
done in serum-free media. For the replenishment of choles-
terol, depleted cells were incubated for 1 h in DMEM containing
6 mg ml1 cholesterol–b-methyl-cyclodextrin complex.
Immunofluorescence
Control and cholesterol-depleted cells grown on glass cover-
slips were treated for 30 min with 107 M PMA (in the case
of macrophages) followed by 7- or 12-min incubation with
FITC–Dextran (1 mg ml1) or 0.1 mg ml1 FITC-labeled
ovalbumin/palmitoylated ovalbumin. Subsequently, cells were
washed and fixed with 3% PFA. For staining, cells were
permeabilized with 0.1% saponin in PBS for 20 min, blocked
with 2% BSA in PBS for a further 20 min and labeled with
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primary and secondary antibodies diluted in PBS/0.1%
saponin/2% BSA for 30–45 min at RT. Internalization of HRP
(5 mg ml1) was performed for 1 h at 37C followed by a chase
of 4 h. Cells were washed extensively, fixed in glutaraldehyde
(0.5% w/v) at RT and internalized HRP was visualized by
incubation with 0.5 mg ml1 diaminobenzidine (Sigma) and
0.05% (v/v) H2O2 in PBS for 10 min. For palmitoylated HRP,
internalization was performed for 1 h with 1 mg ml1 of control
or palmitoylated protein. Afterward, the cells were washed,
fixed and permeabilized with 0.1% saponin for 20 min and
internalized HRP was visualized as described before.
Quantitation of horse radish peroxidase (HRP)
internalization
Control and cholesterol-depleted bone marrow-derived
macrophages were incubated with 2 mg ml1 HRP for 1 h at
37 or 0C, washed and subsequently lysed in 20 mM HEPES,
0.1 M NaCl, 5 mM MgCl2 and 1% (v/v) Triton-X100. The
enzymatic activity of HRP in the lysates was determined by
mixing 10 ll of cell lysate with 200 ll reaction buffer con-
taining 0.342 mM o-dianisidine, 0.003% H2O2 (v/v), 50 mM
sodium phosphate pH 5.0 and 0.3% (v/v) Triton-X100. After
5 min incubation at RT, the absorbance was measured at
455 nm and the obtained values, which correlate with the
amount of HRP in the lysate, were related to the total protein
amount in the lysates.
Flow cytometry
Macrophages were incubated with 0.1 mg ml1 FITC-labeled
ovalbumin or palmitoylated ovalbumin for 20 min at 37C,
washed, fixed with 3% PFA for 30 min on ice and subsequently
analyzed by flow cytometry. Internalization of ovalbumin was
measured as increase in fluorescence and expressed as
mean fluorescence intensity. Shown are the mean values from
three independent experiments.
Video microscopy
Control or cholesterol-depleted cells were placed under
Zeiss Axiovert TV100 equipped with a thermostated (37C)
and CO2-equilibrated chamber (10% CO2). Thirty-minute
video sequences were recorded using a digital camera
(Hamamatsu Photonics Japan) and OpenLab software (ver-
sion 2). Sequences were converted to QuickTime format.
Cross-presentation
Bone marrow-derived macrophages were seeded in 96-well
plates (20 000 cells per well). After PMA stimulation and
cholesterol extraction, cells were incubated with ovalbumin/
palmitoylated ovalbumin or SIINFEKL/palmitoylated SIINFEKL
peptide for 3 h. The non-internalized and non-bound anti-
gens were removed by extensive washing and lymphocytes
(total or CD8+ cells) isolated from OT-1 mice (60) were added
to the bone marrow-derived macrophages (ratio 5:1). T cell
proliferation was measured after 3 days by labeling the
proliferating cells with [methyl-3H]thymidine (Amersham Phar-
macia Biotech). Lactacystin treatment was performed by
incubation of the cells with 10 lM lactacystin 1 h before and
during the 3-h antigen pulse. Fixation with 1% PFA (30 min,
37C) was done prior to incubation with the antigen. The
mean values of one representative experiment are shown in
Figs 4 and 5.
Palmitoylation of ovalbumin and HRP
Palmitoylation was performed following the method of Huang
et al. (52). In brief, 5–30 mg proteins were dissolved in 1 ml of
20 mM NaPP, 150 mM NaCl, 2% deoxycholate pH 8.5. A 20
molar excess of NHS–palmitic acid was dissolved in 100 ll
dioxane. Then 300 ll dimethyl sulfoxide (DMSO) and 100 ll
dioxane containing the NHS–palmitic acid were slowly added
to the protein solution. After overnight incubation, the reaction
was stopped by addition of 1/100 volume of 1 M lysine and free
NHS–palmitic acid was removed by gel filtration (PD 10
column, Amersham Bioscience). To separate palmitoylated
from non-palmitoylated protein, hydrophobic interaction chro-
matography (HIC) was performed. Therefore, proteins were
loaded onto a phenyl superose column (HR 10/10, Pharma-
cia), high salt buffer (20% buffer B, buffer A: 1.7 M ammonium
sulfate, 50 mM sodium phosphate pH 7, buffer B: 50 mM
sodium phosphate) allowing only the binding of palmitoylated
protein. To elute column-bound palmitoylated protein, the salt
concentration was gradually reduced (100% buffer B in 20
min). Palmitoylated proteins were analyzed by mass spec-
trometry or HPLC.
FITC labeling of ovalbumin and palmitoylated ovalbumin
Ovalbumin or palmitoylated ovalbumin was dissolved in PBS
and a 5 molar excess of Oregon Green–NHS in DMSO was
added to the protein solution. The reaction was performed at
RT for 2 h under rotation. The free Oregon Green–NHS was re-
moved afterward bygel filtration (PD10, AmershamBioscience).
Results
Contribution of cholesterol to macropinosome formation
To gain insight into the delivery process of exogenous anti-
gens to the MHC class I-presentation pathway, different
professional APCs were incubated with FITC-labeled Dextran,
a marker for macropinosomes (32, 34, 53). Both J774 cells
and bone marrow-derived macrophages as well as bone
marrow-derived dendritic cells contained large numbers of
macropinosomes (Fig. 1A and B). As macropinosomes pro-
vide a port of entry to deliver components into the cell, similar
to endosomes, the relation of these organelles with other
endocytic compartments was examined. To that end, macro-
phages that had internalized FITC–Dextran via macropinocy-
tosis were analyzed for the presence of different markers of
the endosomal/lysosomal pathway, including clathrin and
LAMP-1, none of which co-localized with macropinosomes.
However, when cells were incubated with the cholesterol-
binding compound filipin (54–56), all macropinosomes strongly
labeled with filipin (Fig. 1B). This suggests that cholesterol is
an important component of macropinosomes in macrophages
and dendritic cells.
To analyze the contribution of cholesterol to macropino-
some formation, the plasma membrane of macrophages and
dendritic cells was depleted for cholesterol by pharmaco-
logical treatment with lovastatin (56). Living cells were ob-
served under the microscope and macropinosome formation
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Fig. 1. Distribution of macropinocytosed FITC–Dextran in macrophages and dendritic cells. (A) Macrophages (J774A.1 cells) were incubated with
FITC–Dextran for 7 min, fixed and stained for clathrin (upper panels) and LAMP-1 (lower panels), followed by Texas red-labeled secondary
antibodies. (B) J774A.1 macrophages (upper panels), bone marrow (BM)-derived macrophages (middle panels) and BM-derived dendritic cells
(lower panels) were incubated for 12 min with FITC–Dextran, fixed and labeled for cholesterol with filipin. Bar: 10 lm.
Fig. 2. Effect of cholesterol depletion on macropinocytosis. (A) J774A.1 cells (right panels), bone marrow (BM)-derived macrophages (middle
panels) or bone marrow (BM)-derived dendritic cells (left panels) were left untreated (control) or cholesterol depleted (depleted) and placed
under a 37C-thermostated and CO2-equilibrated microscope and subsequently 30-min video sequences were recorded. Shown are still images
from the indicated times (see full video sequences at http://www2.biozentrum.unibas.ch/pieters/movies.html) Bar: 10 lm. (B and C) Control (left)
or cholesterol-depleted (right) J774A.1 macrophages (upper panels), BM-derived macrophages (middle panels), or dendritic cells (lower panels)
were incubated with FITC–Dextran for 12 min, fixed and analyzed by fluorescence microscopy. Bar: 10 lm. (C) For quantitation, cells (n ¼ 150)
were scored for the presence of internalized FITC–Dextran. Shown are mean values (6SD) from three experiments. (D) J774A.1 macrophages
(left) or BM-derived macrophages (right) were left untreated (dark gray bars), depleted for cholesterol (light gray bars) or cholesterol-depleted
and replenished by treatment for 1 h with cholesterol–methyl-b-cyclodextrin complex (white bars). Subsequently, cells were incubated for 12 min
with FITC–Dextran. After fixation, the number of FITC–Dextran-positive cells was determined. Shown are mean values (6SD) from three
experiments.
758 Role for cholesterol in cross-presentation
Role for cholesterol in cross-presentation 759
was monitored using time-lapse video microscopy and 30-min
video sequences of control and cholesterol-depleted cells
were recorded. As shown in Fig. 2(A), whereas membrane
ruffling occurred both in control as well as in cholesterol-
depleted cells, macropinosome formation was abolished in
cells depleted of cholesterol (see also movies at http://
www2.biozentrum.unibas.ch/pieters/movies.html). To directly
analyze internalization of the fluid-phase marker FITC–
Dextran, control or cholesterol-depleted cells were incubated
with FITC–Dextran for 12 min, fixed and observed under the
fluorescence microscope. After cholesterol depletion, macro-
phages and dendritic cells were unable to internalize the fluid-
phase marker, in contrast to control cells (Fig. 2B and C).
Internalization of FITC–Dextran was fully restored when
cholesterol-depleted cells were incubated with methyl-
cyclodextrin–cholesterol complex (Fig. 2D), indicating that
cholesterol is necessary for macropinosome formation.
Modulation of internalization by palmitoylation
The finding that macropinosomes are cholesterol-rich struc-
tures, lead us to explore the possibility that enhancement of
the affinity of antigens for cholesterol improves internalization.
One modification that targets proteins to cholesterol-enriched
sites in the plasma membrane is palmitoylation (57–59). As
a model protein, the behavior of HRP after modification by
palmitoylation was investigated. HRP was internalized into
macrophages via macropinocytosis and internalization was
inhibited following cholesterol depletion (Fig. 3A and B).
To modify HRP by palmitoylation, HRP was incubated for
20 h with NHS–palmitic acid (Fig. 3C). After palmitoylation, the
product was purified by HIC (Fig. 3D). Mass spectrometry
analysis showed a mass shift of 239 Da upon palmitoylation
consistent with the addition of one palmitic acid residue.
(Fig. 3E). Internalization of palmitoylated HRP in macrophages
can be blocked by cholesterol depletion, indicating that
palmitoylated HRP is taken up via macropinocytosis (data
not shown). Furthermore, internalization of palmitoylated HRP
is far more efficient compared with non-modified HRP, which
was barely detectable at the same concentration (Fig. 3F).
Together, these results suggest that palmitoylation leads to an
enhanced uptake of exogenous proteins via macropinocytosis.
Role for cholesterol in cross-presentation
Given the role of cholesterol in macropinocytosis, the involve-
ment of cholesterol in cross-presentation was investigated. For
Fig. 3. Palmitoylation of HRP. (A) Control (upper panel) or cholesterol-
depleted (lower panel) bone marrow (BM)-derived macrophages were
incubated for 1 h with HRP (5 mg ml1) and chased for 4 h followed by
fixation. The internalized HRP was visualized as described in Methods.
Bar: 10 lm. (B) Control (dark gray bar) or cholesterol-depleted (white
bar) BM-derived macrophages were incubated for 1 h with HRP
(2 mg ml1). After washing, cells were lysed and the amount of inter-
nalized HRP in the lysate was determined as described in Methods.
Shown are the mean values (6SD) from three experiments. (C) Pal-
mitoylation procedure of HRP. HRP was incubated with an NHS-
activated form of palmitic acid for 24 h allowing the formation of amid
bounds between the acid and primary amino groups of the protein.
The palmitoylated protein was desalted and purified with HIC.
(D) Separation of palmitoylated from unmodified HRP by HIC. The
reaction product as described in panel C was loaded onto phenyl
superose and palmitoylated HRP was eluted after decreasing the salt
concentration by increasing the percentage of buffer B (see Methods).
(E) Mass spectrometry analysis (MALDI-TOF) of control HRP (left
panel) and palmitoylated HRP (right panel). The mass shift of 239 Da
corresponds to the attachment of one palmitic acid chain to the
protein. (F) J774A.1 macrophages were incubated for 1 h with HRP
(1 mg ml1, left panel) or palmitoylated HRP (1 mg ml1, right panel)
fixed and permeabilized. Internalized HRP was visualized as in panel A.
Bar: 10 lm.
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that purpose, we made use of the model antigen ovalbumin.
Ovalbumin labeled with FITC, when added to macrophages,
was efficiently internalized into macropinosomes. Conversely,
internalization of FITC–ovalbumin in cholesterol-depleted cells
was greatly reduced (Fig. 4A and B).
To analyze cross-presentation, control or cholesterol-
depleted macrophages were incubated with ovalbumin for
3 h and washed, and the cell surface display of the ovalbumin-
derived MHC class I SIINFEKL epitope was measured using
Tcells obtained from OT-1 mice that express a TCR specific for
the ovalbumin-derived SIINFEKL peptide (60). The capacity of
the ovalbumin-loaded macrophages to stimulate OT-1 T cells
was quantified by measuring T cell proliferation, which is
a direct result of T cell activation initiated by the recognition of
the appropriated antigen on the surface of the APC.
Whereas control macrophages stimulated T cell prolifer-
ation, depletion of macrophages for cholesterol resulted in
a severely reduced T cell activation (Fig. 4C). To analyze
whether cholesterol depletion compromises the ability to pre-
sent the SIINFEKL peptide per se, untreated and cholesterol-
depleted macrophages were pulsed with SIINFEKL peptide
that does not require internalization prior to presentation to
Fig. 4. Uptake and cross-presentation of ovalbumin in control and cholesterol-depleted cells. (A and B) Macrophages (top panels: J774 A.1;
bottom panels: bone marrow-derived macrophages) were left untreated (control) or depleted for cholesterol (depleted) and incubated with FITC–
ovalbumin (0.1 mg ml1) for 12 min, fixed and analyzed by fluorescence microscopy. Bar: 10 lm. (B) Quantitation was carried out after fixation.
Values represent the percentages of cells having internalized FITC–ovalbumin. Shown are the mean values (6SD, n¼ 50) from three experiments.
(C–F). Bone marrow-derived macrophages were left untreated (dark gray bars) or depleted (white bars) for cholesterol and incubated with
ovalbumin (10 mg ml1) (C, E and F) or SIINFEKL peptide (10 mM) (D) for 3 h. In (E), macrophages were treated with lactacystin. In (F),
macrophages were fixed with PFA prior to addition of ovalbumin (5 mg ml1). Cells were washed and T cells specific for the SIINFEKL epitope
isolated from OT-1 mice were added. T cell proliferation was measured after 3 days as described in Methods.
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T lymphocytes. As shown in Fig. 4(D), both in control or
cholesterol-depleted macrophages, MHC class I presentation
of exogenously added SIINFEKL peptide was comparable.
Ovalbumin was indeed presented after cross-presentation, as
the inclusion of the proteasome inhibitor lactacystin or fixation
of the macrophages with PFA abolished T cell proliferation
(Fig. 4E and F).
Modulation of cross-presentation by palmitoylation of
ovalbumin
Given the dependence of cross-presentation on cholesterol,
we analyzed whether modification of the antigen by palmitoy-
lation could modulate cross-presentation. To that end, oval-
bumin was palmitoylated as described and the capacity of
macrophages to internalize and cross-present palmitoylated
ovalbumin was examined. As shown in Fig. 5(A), internaliza-
tion of FITC-labeled palmitoylated ovalbumin was increased
compared with non-modified FITC–ovalbumin. Quantitation
by flow cytometry suggested an at least 4-fold increase. How-
ever, when macrophages were pulsed with different con-
centrations of ovalbumin or palmitoylated ovalbumin, T cell
proliferation was greatly enhanced following internalization of
palmitoylated ovalbumin as compared with T cell proliferation
induced after internalization of the same concentrations of
ovalbumin (Fig. 5C). The enhanced Tcell proliferation was due
to internalization and processing of the palmitoylated oval-
bumin, as palmitoylated SIINFEKL peptide was far less potent
in the stimulation of T cell proliferation (Fig. 5D) as reported
before (61). Together, these results show that modification
of antigens via palmitoylation increased the ability to be
internalized via macropinocytosis, processed intracellularly
and presented on MHC class I molecules to T lymphocytes.
Fig. 5. Effect of palmitoylation on internalization and cross-presentation. (A) Bone marrow-derived macrophages were incubated with 0.1 mg ml1
ovalbumin (upper panel) or palmitoylated ovalbumin (lower panel) that was labeled with FITC for 12 min, followed by fixation and analysis by
fluorescence microscopy. Bar: 10 lm. (B) Bone marrow-derived macrophages were incubated with FITC-labeled ovalbumin (white bars) or
palmitoylated ovalbumin (dark gray bars) for 20 min at 37C, fixed and protein internalization analyzed by FACS. Shown are mean values (6SD)
from three experiments. (C) Bone marrow-derived macrophages were incubated for 3 h with ovalbumin (white bars) or palmitoylated ovalbumin
(dark gray bars). Cells were washed and Tcells specific for the SIINFEKL epitope isolated from OT-1 mice were added, and Tcell proliferation was
measured as described in Methods. (D) Bone marrow-derived macrophages were incubated with 10 mM of SIINFEKL peptide or palmitoylated
SIINFEKL peptide for 3 h.
762 Role for cholesterol in cross-presentation
Discussion
Initiation of the immune response against infectious organ-
isms occurs through the presentation of antigenic peptides
by professional APCs, such as macrophages and dendritic
cells. Elimination of viruses occurs largely through the activity
of CTLs that become activated after presentation of viral
antigens on MHC class I molecules. In recent years, it is
becoming clear that these MHC class I-restricted antigens
not only derive from endogenously synthesized proteins but
that also exogenous proteins are a source for antigenic
peptides presented via MHC class I (28, 30, 62). This ‘cross-
presentation’ of exogenous antigens ensures the generation
of an immune response when APCs are not infected by viruses
itself and is thought to be important in the establishment of
an immune response against tumors. In professional APCs
such as macrophages and dendritic cells, one mechanism to
internalize antigens for cross-presentation occurs via macro-
pinocytosis (63). In this work, we show that internalization of
antigens into macrophages and dendritic cells via macro-
pinocytosis required the presence of cholesterol. Furthermore,
modification of the model antigen ovalbumin with palmitoyla-
tion dramatically increased cross-presentation. These results
suggest that modification of antigens to increase their affinity
for cholesterol may be exploited to enhance the activation of
CD8+ lymphocytes.
What role does cholesterol play in macropinosome forma-
tion? Phagocytosis is not affected in cholesterol-depleted
macrophages (56) and therefore cholesterol is not necessary
for the membrane curvature during the process of macro-
pinosome formation. Recent findings in the epidermoid
carcinoma cell line A431 showed the dependence of
cholesterol for the plasma membrane localization of Rac 1
(41). Cholesterol depletion of A431 cells prevented plasma
membrane localization of Rac 1 upon phorbol ester treatment
thereby blocking membrane ruffling and macropinosome
formation. In macrophages and dendritic cells, depletion of
cholesterol abolishes macropinosome formation but does not
affect membrane ruffling which is known to be independent
of Rac 1 (44). Therefore, cholesterol depletion may inhibit
macropinosome formation by blocking plasma membrane
localization of Rac 1 also in professional APCs such as
macrophages and dendritic cells.
Besides a role for cholesterol in the internalization process
of soluble antigens into macropinosomes, it is likely that
there is an additional role for cholesterol in the cytosolic
translocation of these antigens to allow cross-presentation.
This is based on our finding that while internalization of
palmitoylated antigen was increased ~4-fold as determined
by flow cytometry, presentation of ovalbumin-derived peptide
was increased up to ~200-fold when the palmitoylated form
of ovalbumin was administered. Cross-presentation of oval-
bumin is dependent on the functioning of the proteasome,
suggesting that translocation to the cytosol is required, but
how exactly antigens are entering the cytoplasm for process-
ing and presentation on MHC class I molecules remains
unclear.
Several models to explain MHC class I presentation of
exogenous antigens have been put forward. First, antigens
could be internalized through different forms of endocytosis,
including phagocytosis and macropinocytosis, followed by
antigen degradation within such organelles and antigenic
peptide loading on recycling MHC class I molecules.
Second, antigens could be transferred to the cytosol where
proteolytic activity of the proteasome would generate
antigenic peptides to be translocated into the ER followed
by presentation on ER-resident MHC class I molecules
(18, 64).
Cross-presentation is blocked when APCs are incubated
in the presence of proteasome inhibitors (32, 65). As pro-
teasomes are not known to reside within endocytic organ-
elles, this suggests that cytosolic translocation of the antigen
has to occur in order to generate the appropriate peptides.
How do protein antigens acquire access from endosomal
organelles such as phagosomes and macropinosomes to the
cytosol? One recently proposed possibility involves the same
machinery that is responsible for translocation of misfolded
proteins from the ER, namely the Sec61 translocon. In-
terestingly, in Dictyostelium discoideum, several resident ER
proteins are necessary for phagocytosis (66). More recently,
based on the localization of resident ER proteins within
phagosomes (67), it has been proposed that phagosomes
intersect with the ER. The ER elements could thereby provide
most of the processing and presentation components
required for MHC class I-restricted antigen presentation
(29, 62, 68, 69). However, the concept of ER-mediated
phagocytosis is questioned by a recent report where
a contribution of the ER to the phagosome formation was
not observed (70).
Whether or not molecules of the Sec61 translocation com-
plex are involved in transport of antigenic peptides generated
by the proteasome as well as import of antigens into the
cytosol is unknown. Interestingly, cholesterol renders the
Sec61 translocon machinery unable to recognize and/or
initiate translocation of nascent polypeptide chains (71). As
import of antigens from macropinosomes to the cytosol is
topologically similar to retro translocation, cholesterol may
play a role in ensuring cytosolic import of substrates, while
blocking the activity of the Sec61 complex for passage of
nascent chains.
The requirement for cholesterol in delivering exogenous
antigens to the MHC class I-processing and -presentation
pathways could be utilized to enhance the immune response
against defined antigens. As shown here, palmitoylation of
ovalbumin to increase its affinity for cholesterol (58, 59)
dramatically enhanced the capacity of APCs loaded with this
modified antigen to stimulate T lymphocytes. This is in contrast
to the capacity of palmitoylated peptides that do require
internalization and processing to trigger T cell activation,
which is similar to or even lower than the non-modified
peptides (61). The increase in T cell stimulatory capacity far
exceeded the enhanced internalization of palmitoylated oval-
bumin, suggesting that cholesterol plays an important role in
the actual translocation process.
The potential of palmitoylation to enhance the immunity
against exogenous antigens could be used for vaccine devel-
opment against viruses and tumors (72). This approach might
especially be useful when using protein antigens which,
compared with peptides, have a greatly increased stability
in vivo.
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APC antigen-presenting cell
DMSO dimethyl sulfoxide
ER endoplasmic reticulum
HIC hydrophobic interaction chromatography
LAMP-1 lysosomal-associated membrane glycoprotein-1
PI phosphatidylinositol
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RT room temperature
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